These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21510895)

  • 81. [Analysis of methylphenidate's efficacy using the abbreviated version Conners' questionnaire in attention deficit hyperactivity disorder].
    de Andrade ER; Scheuer C
    Arq Neuropsiquiatr; 2004 Mar; 62(1):81-5. PubMed ID: 15122438
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder.
    Bouffard R; Hechtman L; Minde K; Iaboni-Kassab F
    Can J Psychiatry; 2003 Sep; 48(8):546-54. PubMed ID: 14574830
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Transitioning to OROS(®) methylphenidate from atomoxetine is effective in children and adolescents with ADHD.
    Niederkirchner K; Slawik L; Wermelskirchen D; Rettig K; Schäuble B
    Expert Rev Neurother; 2011 Apr; 11(4):499-508. PubMed ID: 21469923
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial.
    Dehbozorghi S; Bagheri S; Moradi K; Shokraee K; Mohammadi MR; Akhondzadeh S
    Psychiatry Clin Neurosci; 2019 Nov; 73(11):690-696. PubMed ID: 31294924
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom control.
    Sonuga-Barke EJ; Coghill D; Wigal T; DeBacker M; Swanson J
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):683-90. PubMed ID: 20035586
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
    Pliszka SR; Wilens TE; Bostrom S; Arnold VK; Marraffino A; Cutler AJ; López FA; DeSousa NJ; Sallee FR; Incledon B; Newcorn JH
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):474-482. PubMed ID: 29172680
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities.
    Gucuyener K; Erdemoglu AK; Senol S; Serdaroglu A; Soysal S; Kockar AI
    J Child Neurol; 2003 Feb; 18(2):109-12. PubMed ID: 12693777
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan.
    Takahashi N; Koh T; Tominaga Y; Saito Y; Kashimoto Y; Matsumura T
    World J Biol Psychiatry; 2014 Aug; 15(6):488-98. PubMed ID: 24456065
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.
    Kooij JJ; Burger H; Boonstra AM; Van der Linden PD; Kalma LE; Buitelaar JK
    Psychol Med; 2004 Aug; 34(6):973-82. PubMed ID: 15554568
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Effect of parent training in combination with methylphenidate treatment on family relationships for children with attention deficit/hyperactivity disorder].
    Zhang Y; Kang CY; Zhao XR; Xuan X; Ding KJ; Liu RX; Wang YJ; Yang RX; Li XR; Wan S
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):185-9. PubMed ID: 24568915
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder.
    Gadow KD; Sverd J; Sprafkin J; Nolan EE; Ezor SN
    Arch Gen Psychiatry; 1995 Jun; 52(6):444-55. PubMed ID: 7771914
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
    Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Response to methylphenidate in children with ADHD and comorbid anxiety.
    Diamond IR; Tannock R; Schachar RJ
    J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):402-9. PubMed ID: 10199111
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study.
    Wolff C; Alfred A; Lindermüller A; Rettig K; Mattejat F; Gerwe M; Slawik L; Schäuble B
    Curr Med Res Opin; 2011; 27 Suppl 2():35-44. PubMed ID: 21787126
    [TBL] [Abstract][Full Text] [Related]  

  • 95. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
    Greenhill L; Kollins S; Abikoff H; McCracken J; Riddle M; Swanson J; McGough J; Wigal S; Wigal T; Vitiello B; Skrobala A; Posner K; Ghuman J; Cunningham C; Davies M; Chuang S; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2006 Nov; 45(11):1284-1293. PubMed ID: 17023867
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Parental reporting of adverse drug reactions associated with attention-deficit hyperactivity disorder (ADHD) medications in children attending specialist paediatric clinics in the UK.
    Tobaiqy M; Stewart D; Helms PJ; Williams J; Crum J; Steer C; McLay J
    Drug Saf; 2011 Mar; 34(3):211-9. PubMed ID: 21332245
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    Fageera W; Grizenko N; Sengupta SM; Schmitz N; Joober R
    J Atten Disord; 2021 Oct; 25(12):1720-1730. PubMed ID: 32564645
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Can parents believe websites' information about methylphenidate's side effects?
    Arsac England T; Tuthill D
    Arch Dis Child; 2021 Oct; 106(10):1015-1017. PubMed ID: 33785529
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Sensitivity of scales to evaluate change in symptomatology with psychostimulants in different ADHD subtypes.
    Grizenko N; Rodrigues Pereira RM; Joober R
    J Can Acad Child Adolesc Psychiatry; 2013 May; 22(2):153-8. PubMed ID: 23667362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.